Agenda and Related Documents

• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Final Agenda (PDF - 17KB)
• September 9, 2009: Vaccines and Related Biological Advisory Committee Voting Record for Cervarix (PDF - 18KB)
• September 9, 2009: Vaccines and Related Biological Advisory Committee Voting Record for Gardasil (PDF - 16KB)
• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: Cervarix: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (PPT - 107KB)
• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: Questions for the Committee (PPT - 101KB)
• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: Cervarix: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (PPT - 573KB)
• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: Cervarix: Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (PPT - 138KB)
• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: Male Indication for Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] (PPT - 380KB)

Other Presentations

Persons with disabilities having problems accessing these PowerPoint files may call 301-827-0314 for assistance.

• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: GlaxoSmithKline - Cervarix (PPT - 5.5MB) Barbara Howe, M.D.
• September 9, 2009: Vaccines and Related Biological Products Advisory Committee Meeting Presentation: Use of GARDASIL in Boys and Men (PPT - 1.9MB) Dalya Guris, MD, MPH